| Symbol | DYAI |
|---|---|
| Name | DYADIC INTERNATIONAL INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL 33477 |
| Telephone | 561-743-8333 |
| Fax | — |
| — | |
| Website | https://www.dyadic.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001213809 |
| Description | Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - DYADIC INTERNATIONAL INC <b>Filed:</b> 2026-08-17 <b>AccNo:</b> 0001493152-26-038664 <b>Size:</b> 7 KB
Read moreNew Form 424B5 - DYADIC INTERNATIONAL INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001493152-26-037870 <b>Size:</b> 311 KB
Read moreDyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement
Read more(30% Negative) DYADIC INTERNATIONAL INC (DYAI) Reports Q3 2026 Financial Results
Read moreDyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Read moreDyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas
Read moreDyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Read moreDyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Read moreDyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Read moreDyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Read more